Category: Pharmaceuticals
The study specifies the possibility of preventing or delaying kidney failure and the need for dialysis or a kidney transplant in patients with rare chronic kidney disease. U.S. clinical-stage biopharmaceutical firm, Reata Pharmaceuticals, Inc. has recently announced its final, positive result from the focal segmental …
The FDA will decide on the definitive approval by the 19th of August 2019. The U.S. Food & Drug Administration (FDA) has reportedly accepted the BLA (Biologics License Application) submitted by the Swiss multinational healthcare company, Roche. The company has been officially granted Priority Review …
Glenmark Pharmaceuticals, the Mumbai-headquartered pharmaceutical company, has made it to the front page for receiving the USFDA (United States Food & Drug Administration) nod for its generic version of skin inflammation treatment foam, Olux foam 0.05 per cent of Mylan Pharmaceuticals. As per IQVIA sales …
Shenzhen Chipscreen Biosciences Ltd., a leading China-based integrated biotech company, has reportedly entered into a collaboration agreement with Innovent Biologics Inc., a Chinese development-stage biopharmaceutical company, in a major effort to evaluate the tolerability and safety of the combination therapy involving Innovent’s Sintilimab and Chipscreen’s …
AbCellera Biologics Inc., the antibody therapeutics developer based in Vancouver, has reportedly entered into a multi-year, multi-target partnership agreement with Novartis International AG, the Swiss multinational pharmaceutical company. Reportedly, the agreement entails the identification of antibodies for about ten therapeutic targets in the pipeline of …
Nano Graphene Inc. (also known as GrapheneCA), a US-based supplier of graphene-based materials, has reportedly announced its plans to make graphene readily available for use in the cosmetics and pharmaceutical industries. Reportedly, GrapheneCA’s latest move helps in paving the path for the introduction & licensing …
The globally reputed Aurobindo Pharma, based in Hyderabad, has apparently made it to the front page for having categorically closed the acquisition of Apotex’s commercial operations in addition to a select few supporting infrastructure across five major countries in Europe. As per sources familiar with …
Reports confirm that Glenmark Pharmaceuticals has recently secured a final approval by the U.S. Food and Drug Administration (US FDA) for 400 mg and 800 mg Sevelamer Hydrochloride Tablets, which is a generic version of Genzyme Corporation’s Renagel Tablets, 400 mg and 800 mg. According …
Switzerland healthcare authorities approve Kerecis Omega3 Wound Kerecis plans to buy Phytoceuticals for establishing sales channel in Switzerland As of March 1, 2019, doctors would be able to prescribe Kerecis Omega3 Wound Kerecis, the firm which has pioneered tissue regeneration through fish skin, has …
